Abiopharma

Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call

Coherus Oncology to Participate in Upcoming Investor Conferences

Genprex Announces Registered Direct Offering of up to $8.2 Million Priced At-The-Market Under Nasdaq Rules

📋 Rozen Limor (Director) plans to sell 15K shares of Inspira Technologies OXY B.H.N. Ltd (at $1.13 each, total $17K) Filed: Oct 22, 2025 | ID: 000337

New Form 6-K - Quantum Biopharma Ltd. Filed: 2025-10-23 AccNo: 0001171843-25-006619 Size: 27 KB

(30% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Announces Delay in well Trials for future growth Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

(94% Neutral) ENDRA Life Sciences Inc. (NDRA) Announces Business Combination

(75% Positive) GRACE THERAPEUTICS, INC. (ACST) Announces Regulatory Update

(35% Negative) INTEGER HOLDINGS CORPORATION (ITGR) Reports Q4 2025 Financial Results

Avantor, Inc. - Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance